Basic Information
Basic information for NR2F1-AS1-270-13aa-2
Peptide Name NR2F1-AS1-270-13aa-2
Genome Position chr5:93506217-93506255[-]
Species Human
Peptide Sequence MIWFGCVPTQIST
Peptide Length 13
Unique No (ENTPD1-AS1-201-13aa,ENTPD1-AS1-207-13aa,AC093606.1-201-13aa-1,ENTPD1-AS1-214-13aa-3,ENTPD1-AS1-215-13aa-3,ENTPD1-AS1-216-13aa-3,AC019294.2-213-13aa-2,ENTPD1-AS1-219-13aa-2,ENTPD1-AS1-220-13aa-1,ENTPD1-AS1-221-13aa-1,ENTPD1-AS1-222-13aa-3,ENTPD1-AS1-223-13aa-2,AC021573.1-201-13aa,ENTPD1-AS1-228-13aa-2,ENTPD1-AS1-229-13aa-1,ENTPD1-AS1-231-13aa-1,ENTPD1-AS1-232-13aa-1)
Grand Average of Hydropathicity 0.9077
Relative Molecular Mass 1699.03
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000237187;NR2F1-AS1
Transcript ID/Name ENST00000670693;NR2F1-AS1-270
Transcript Length 2828
Coding Ability 0.3561
DNA Sequence Corresponding to Peptide ATGATATGGTTTGGCTGTGTCCCTACCCAAATATCAACT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :